Rocket Pharmaceuticals (RCKT) Prepaid Assets (2014 - 2026)
Rocket Pharmaceuticals' (RCKT) quarterly Prepaid Assets came in at $5.4 million in Q1 2026, down 13.92% year-on-year from $6.3 million in Q1 2025, and up 43.18% quarter-over-quarter from $3.8 million in Q4 2025.
Rocket Pharmaceuticals (RCKT) Prepaid Assets (2014 - 2026) Analysis & Trends
Rocket Pharmaceuticals has disclosed Prepaid Assets across 13 years of filings, most recently posting $5.4 million for Q1 2026.
- Prepaid Assets for Q1 2026 came in at $5.4 million, down 13.92% year-over-year; the trailing twelve-month figure through Mar 2026 was $5.4 million (down 13.92% YoY), and the FY2025 annual result was $3.8 million, down 34.92% from the prior year.
- Prepaid Assets came in at $5.4 million for Q1 2026 at Rocket Pharmaceuticals, up from $3.8 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $14.8 million in Q1 2024 to a low of $3.8 million in Q4 2025.
- The 5-year median for Prepaid Assets is $5.8 million (2024), against an average of $6.9 million.
- Across the five-year window, Prepaid Assets soared 176.12% in 2024 and tumbled 59.27% in 2025, its largest moves.
- Rocket Pharmaceuticals' Prepaid Assets stood at $7.7 million in 2022, then sank by 34.16% to $5.0 million in 2023, then advanced by 15.85% to $5.8 million in 2024, then plunged by 34.92% to $3.8 million in 2025, then jumped by 43.18% to $5.4 million in 2026.
- The last three Prepaid Assets figures came in at $5.4 million (Q1 2026), $3.8 million (Q4 2025), and $4.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Rocket Pharmaceuticals | 308.37 Mn | 308.37 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.45 Mn |
| Dec 31, 2025 | 3.81 Mn |
| Sep 30, 2025 | 4.92 Mn |
| Jun 30, 2025 | 5.66 Mn |
| Mar 31, 2025 | 6.33 Mn |
| Dec 31, 2024 | 5.85 Mn |
| Sep 30, 2024 | 6.09 Mn |
| Jun 30, 2024 | 13.90 Mn |
| Mar 31, 2024 | 14.85 Mn |
| Dec 31, 2023 | 5.05 Mn |
| Sep 30, 2023 | 9.69 Mn |
| Jun 30, 2023 | 5.03 Mn |
| Mar 31, 2023 | 6.95 Mn |
| Dec 31, 2022 | 7.67 Mn |
| Sep 30, 2022 | 4.60 Mn |
| Jun 30, 2022 | 4.40 Mn |
| Mar 31, 2022 | 7.26 Mn |
| Dec 31, 2021 | 3.32 Mn |
| Sep 30, 2021 | 3.61 Mn |
| Jun 30, 2021 | 3.60 Mn |